Your session is about to expire
← Back to Search
Digital Diabetes Self-Management for Diabetes (Dulce Digital Trial)
Dulce Digital Trial Summary
This trial will compare the effectiveness of two digital approaches to improving self-management and digital health skills of underserved participants with diabetes, compared to traditional in-person self-management education.
Dulce Digital Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowDulce Digital Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Dulce Digital Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not willing to carry a mobile phone.I am too ill to visit the clinic for treatments.I have severe hearing or vision problems.I have been diagnosed with Type 2 Diabetes.I have been cancer-free for over 2 years, or I only had skin cancer.Your liver function tests show that your liver may not be working well.Your body mass index is less than or equal to 23.Adults who are Hispanic/Latino and are patients at Scripps Health.My primary language is not English or Spanish.Your blood sugar level (HbA1c) has been higher than 8% in the last two months.I have not donated blood or plasma recently.Your creatinine level is higher than 3.5.I have been diagnosed with Type 2 Diabetes.I have anemia.Currently participating in diabetes self-management education or support.Hispanic/Latino adults who are patients at Scripps HealthYour average blood sugar level (HbA1c) has been 8% or higher in the last two months.
- Group 1: Dulce Digital
- Group 2: Project Dulce Telehealth DSME/S
- Group 3: Project Dulce Live DSME/S
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is it currently feasible for individuals to enroll in this experiment?
"The clinicaltrials.gov portal reveals that this trial is no longer enrolling patients, despite the fact it was initially posted on November 1st 2022 and last edited nine days later. But there are 1392 other medical studies actively recruiting at present."
What is the intended goal of this medical research?
"This trial will be evaluated over a 3-month period, its primary outcome being the Change from Baseline in Glycosylated Hemoglobin A1C (HbA1c) at 6 months. Alongside that, secondary endpoints include the Diabetes Distress Scale (DDS-17), which assesses overall emotional distress related to diabetes on a 1-6 scale; as well as assessing Treatment Satisfaction with 8 questions ranging from 0 ("very dissatisfied", "very inconvenient") to 6 ("very satisfied", "very convenient"). This is further divided into two factors: one gauging satisfaction and willingness to continue treatment (total score"
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger